DXCM
$364.49
Dexcom
$19.64
5.70%
DXCM
Earnings Whisper ®
N/A
2nd Quarter June 2020
Consensus:  $0.28
Revenue:  $405.37 Mil
Tuesday
Jul 28
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Tuesday, April 28, 2020

What do you expect when DXCM reports earnings?
Beat
Meet
Miss

Where is DXCM's stock price going from here?
Up
Flat
Down
Stock chart of DXCM
Analysts
Summary of analysts' recommendations for DXCM
Score
Grade
Pivots
Resistance
$407.33
$387.37
$375.93

$355.98

Support
$344.54
$324.58
$313.14
Tweet
Growth
Description
Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.
Peers
StrykerBoston ScientificAbbottBecton, DickinsonBaxter InternationalWatersIntegra LifeSciences HoldingsTeleflex3MAbiomed